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Abstract
Building capacity for developing skills as leadership, teamwork, and continuous academic
support has become essential for fulfilling a successful pharmacy career. This study aims
to assess Jordanian pharmacists’ views on professional development, namely: the contin-
uous education infrastructure, strategies and programs for personal development, leader-
ship skills, incentive schemes, drug information resources and digital services. As well
as exploring options for better academic support delivered to pharmacists. To capture par-
ticipant’s views, an online validated and reliable survey was developed. Non-probability
sampling design was used. Participants were qualified pharmacists working at Royal
Medical Services (RMS) and Community Pharmacists (CP). Comparison and descriptive
statistics were used to report the results. A total of 271 pharmacists participated, 144 from
RMS (8% more than the needed sample) and 127 CP (7% more than the needed sample).
There was a strong desire amongst both RMS and PC groups for continuous educational
training particularly in the following areas, first: Advanced counselling and communication
skills (means = 8.99±0.145, CI 95% = 3.70–4.28 and 9.37±0.096, CI 95% = 4.18–4.56).
Second: Personal development skills (mean = 8.92±0.142, CI 95% = 3.64–4.20 and 9.02
±0.145, CI 95% = 3.73–4.30). Third, Pharmaceutical health promotion (mean = 8.05
±0.180, CI 95% = 2.70–3.41 and 8.57±0.159, CI 95% = 3.26–3.89). Only 19.4% and 18.1%
of the RMS and CPs respectively reported the presence of a written policy for personal
development and leadership in their workplace. There were few incentives for pharmacists
to participate in research. Few pharmacists used the available drug information and toxi-
cology centers. The professional and continuous personal development of pharmacists
support an evolving healthcare system. This study emphasizes the need for a tailored and
documented postgraduate educational strategy, personal development, and leadership
skills training in Jordan. Implementing a well-defined scheme of incentives should be
encouraged to engage pharmacists in continuous professional development programs and
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pharmaceutical research. Such strategy and training should enhance both professional
and personal performance.
Introduction
Healthcare professionals are expected by their regulatory bodies and key stakeholders includ-
ing the public, to provide patient-oriented and evidence-based medical interventions and
advice. It is imperative that they remain competent in their field of practice and committed to
excellence in healthcare throughout their career. Keeping their theoretical knowledge and
practical skills current is essential to meet the challenges and demands of evolving societal and
individual healthcare needs, health service delivery and professional responsibilities. In addi-
tion to retaining and developing theory and practice, there is increasing emphasis on personal
development of the individual healthcare professional. This is achieved through enhancing
transferable or so-called ‘soft’ skills e.g. improving interpersonal communication, reflective
practice, problem solving and team work [1].
Pharmacists are integral members of the healthcare workforce. The role of the pharmacist
however is rapidly evolving, and the boundaries between many non-medical professional and
medical professional responsibilities are blurring. Previously, pharmacists were described as
the ‘medicines experts’ and their role reflected this, primarily focusing around medicine pro-
curement and supply. However, this is changing and pharmacists are increasingly patient fac-
ing and directly involved in clinical consultations and medicines management processes.
Pharmacists working in hospital, community and General Practice settings should engage
with patients, their careers, and other healthcare professionals to improve patient health out-
comes by looking at the patient from a more holistic view including disease state, medication
management, and social health and well-being. This process of direct engagement falls under
the remit of the medicines reconciliation process and has shown to improve medication adher-
ence and attitudes towards pharmacological and non-pharmacological interventions [2].
Through working collaboratively with other healthcare professionals, patients and their fami-
lies a patient-centred plan is developed. Optimal pharmaceutical care has a positive impact on
patients’ clinical, humanistic, and economic outcomes [3].
To achieve optimal and current pharmaceutical care pharmacists, like many healthcare pro-
fessionals, are expected to engage in continuous education (CE) or continuous professional
development (CPD) post-qualification. In other words, pharmaceutical training and education
for pharmacists are required to maintain and improve their knowledge and meet both evolving
individual patient and society’s healthcare needs [4]. In countries, such as the United Kingdom
(UK) and United States (US) this has been a requirement of the professional regulators for
many years. How pharmacists demonstrate their competence and continued learning is often
left to the individual to decide. Unless they engage in further formal education, training
resources and sessions may be limited following qualification [4, 5]. Often the terms CE and
CPD are used interchangeably. CPD however is considered a more involved process of self-
directed learning and perhaps more beneficial in terms of healthcare as the focus is on sup-
porting competence through reflection and application of learning to practice. The primary
goal of CE on their other hand is participation. CPD encompasses the higher levels of Blooms
taxonomy of learning and encourages the cycle of reflection, planning and undertaking of
learning, and evaluation of its impact on practice [6],
In Jordan, Saudi Arabia and Kuwait pharmacists complete a Bachelor of pharmacy
(BPharm) degree programme [7]. Further formal pharmacy education is obtained through
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completion of a master’s degree program, preregistration training, a final registration exami-
nation, and -to some extent- an internship in a practice setting [8]. A recent systematic review
carried out by Micallef and Kayyali [6], indicated that pharmacists prefer face to face and inter-
active e-learning as methods for delivery of CPD. Although there are elements of e-learning
incorporated into Jordanian BPharm programs and this approach is proving useful for CPD in
the UK, within Jordan there remains a major gap between formal university education and for-
mal CPD training for those in professional practice [9]. The questions remain as to, who
should provide CPD training? Should training be directly linked to area of practice only? and
which delivery format is best for Jordanian pharmacists? CPD programmes across the globe
tend to focus on improving knowledge around specific topics such as smoking cessation [10]
herbal medicines and antibiotics [5, 11], partnership training methodologies with community
partners [12], using pseudo-patients and performance feedback techniques [13]. Alternative
events that may be considered as CPD include participation in workshops and conferences
[14], and development of ‘soft’ skills e.g. leadership training, working with others and personal
development.
Leadership has been widely discussed and identified based on several perspectives. Gener-
ally defined, leadership is a combination of position, attitude, skills, responsibilities and behav-
iours that enable an individual or group of individuals to “make things better” in a sustainable
manner [15, 16]. Pharmacy, like other healthcare disciplines, requires appropriate leadership
in order to facilitate sustainable and positive changes in pharmacy, from product-based to
patient-oriented practices [17, 18].
Leadership in clinical pharmacy practice entails optimizing pharmaceutical care delivery,
development of feasible remuneration models, implementation and effective activation of
patient-oriented practices, professional advancement, and the strategic planning and embed-
ding of the aforementioned principles in pharmaceutical education programs [19]. Such lead-
ership will enable transformation of the pharmacy profession and in turn influence the
societies and patients with whom pharmacists engage with [20]. Although leadership is a desir-
able trait for pharmacists to have, how we define leadership, teach and assess it remains incon-
clusive [21]
Several countries including the US and Canada have raised concerns regarding an impend-
ing potential pharmacy leadership crisis. This is attributable to the continuous evolution of
practice and negligence of teaching leadership skills in pharmacy education programs. This
combined with an ageing existing pharmacy leadership, leaves a gap in direction and vision for
the profession [18, 22–25]. Pharmacists in many cases lost their influencing and leadership
roles due to either working in small independent pharmacies where their voices are considered
too small to notice, or larger chain pharmacies where such practices are limited to senior man-
agers only rather than individuals on the frontline.
It is generally accepted that leadership skills are obtained and learned rather than inherited.
There is increasing drive to improve leadership training at both undergraduate and postgradu-
ate professional levels. In Jordan, universities follow The Accreditation Council for Pharmacy
Education (ACPE). ACPE guideline 17.3 suggests not only the inclusion of leadership skills in
the curriculum but also the evaluation of leadership skills for admission purposes [25]. The
increasing demands are to prepare individuals that can lead rather than blindly do their profes-
sional tasks for enhancing patient centralized pharmaceutical care [26]. This encompasses
employment of the required skills including; effective connections with other health practi-
tioners and administrators, students teaching, fellows teaching, and patient pharmaceutical
and clinical care [19]. To plan, explore, and assess programs, pharmacy leadership training has
been discussed by researchers, where they identified a lack of original work, valid instruments
for assessment, studies based on theoretical constructs, individual leadership traits and
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perceptions rather than demonstrations of practice over time [21]. Thus this is an area within
pharmacy education where there is scope for improvement and development of appropriate
training.
Working with others is crucial for success regardless of role or duties. Staff motivation,
Emotional intelligence (EI), and satisfaction are major influencers of job satisfaction levels
[27]. High job satisfaction and motivation are associated with increased productivity, innova-
tion, and enhancement of an organization’s overall performance [28, 29]. Generally speaking,
job satisfaction is a combination of psychological, environmental, and physiological circum-
stances that have a positive influence on the employee’s feelings towards his/her job [27, 30].
Various factors play a role in job satisfaction including salary, benefits, regulations, job secu-
rity, work conditions, and recognition of superior performance [31]. The latter is a key factor
in employees’ motivation to strive for better individual performance and outstanding work.
As pharmacist roles are expanding, the drive for further education to advance in their profes-
sional skills is aided through participation in CPD including adoption of patient counseling and
clinical recommendations based on the latest evidence “Pharmacy Practice Based Research
(PPBR)” [32, 33]. Pharmaceutical care and indeed healthcare and its associated research through-
out the world is increasingly answerable to all stakeholders involved. It therefore must demon-
strate that it is patient-centred and evidenced-based. Adopting this approach improves the quality
of pharmaceutical care and contributes to widening the scope of pharmacy practice [34].
The majority of pharmacy-related literature is obtained from researches that emerged from
universities, hospitals, academically affiliated clinics, pharmaceutical companies, and organiza-
tional bodies [35]. However, a shy body of literature has emerged from community pharma-
cies, this can be attributed to several factors including the lack of grants for community
pharmacies research, lack of information regarding the willingness of their participation in
research, the majority of community pharmacies are privately owned business which is, in
turn, profit-oriented, lack of time, lack of support, unawareness of the available opportunities,
among others [34–37].
The most recent efforts for CPD in pharmacy has been endorsed by the International Phar-
maceutical Federation (FIP), which outline that it is “the responsibility of an individual phar-
macist for systematic maintenance, development and broadening of knowledge, skills and
attitudes to ensure continuing competence as a professional throughout their career” (Adepu
and Shariff, 2010). The FIP announced the Pharmaceutical Workforce Development Goals
(PWDGs), a set of 13 measurable, feasible, and achievable goals, divided into three clusters:
Academy, Professional Development, and Systems, in order to facilitate pharmacy workforce
development [38].
In the Middle East in general, and Jordan in particular, professional development, job satis-
faction, motivation, leadership, CE, and the emerging role of pharmacists in pharmaceutical
care and patient centralized management are considerably behind our European, American
and Australian colleagues in particular [39]. To address this, several interventions have been
made. The Pharmacists in Royal Medical Services (RMS) now choose a defined career pathway
either within procurement or clinical services. Community pharmacists (CP) have increased
opportunity to attend workshops sponsored or coordinated by the Jordanian Pharmacist Asso-
ciation (JPA) to facilitate CPD and CE. Recently the JPA announced regulations to adopt
credit hours of CPD in the annual membership renewal conditions, and announce a partner-
ship with the International Pharmaceutical Federation (FIP) to create and support the process
of CPD. Subsequently, adopting similar approaches in pharmacy schools and post-graduate
training from across the globe.
Considering recent changes within Jordan, this study aims to investigate and assess Jorda-
nian pharmacists’ views about professional development including: The infrastructure for
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continuous pharmaceutical education and training within Jordan, Personal development and
leadership, Incentives and rewards, Digital services and software for pharmacy management,
Academic support and sources of information.
Materials and methods
Survey development
The survey was comprised of mixed mood questions type: closed ended questions, scoring
questions and open ended questions (S1 Data) and designed to capture participant demo-
graphics and divided into two main sections:
Section 1: assessed professional development including CE infrastructure, strategies and
programs for personal development and leadership skills, incentive schemes, drug information
resources and digital services.
Section 2: investigated suggestions to enhance personal development academic support,
including academic courses.
The survey was assessed for Face validation and Criterion validity [40] by the steering com-
mittee, who have experience and expertise in pharmacy practice (5 consultant pharmacists in
RMS, 3 senior pharmacists that work for the JPA, and specialists in pharmacy practice in addi-
tion to authors of this paper.
Reliability measures for internal consistency and stability over time were confirmed by
Cronbach’s alpha analysis and Pearson correlation respectively. The questionnaire was tested
on a pilot sample of 23 responder. Responders were contacted first time and 15 days later to
complete the questionnaire again (pre-/posttest reliability was performed) to justify moving
forward with a large-scale pilot test. The coefficient alpha was high (Cronbach’s alpha = 0.74)
[41] and very strong test-retest reliability (Pearson’s r = 0.92) [42, 43].
Sample selection
To collect high quality and reliable data the novel non-probability sampling design "voluntary
sampling design was adopted [44]. The steering committee agreed on the following target pop-
ulation. Inclusion criteria:
• Qualified pharmacists working at RMS (population N = 200)
• Qualified pharmacists working at community pharmacies and listed as Hashemite university
partners for training and development (population N = 170)
Exclusion criteria: Pharmacists not working at RMS nor community pharmacies were excluded.
Sample size calculation
In terms of estimating expected response numbers the Yamane Eq 1 was applied (Yamane,
1967). With a suggested E (sampling error) of 5%, the n (sample size) would be 133 for RMS





Ethical approval and survey distribution
Ethical approval was sought for the study and granted by the Institutional Review Board of the
Royal Medical Services Reference 9/24/10/2019. To capture the desired data a purposeful
online survey was circulated through the Google survey platform.
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Participants that met the aforementioned inclusion criteria were invited to complete the
online survey by a link sent to their WHATSAPP accounts. Data collected from RMS staff
between Oct-Dec 2018, and Community pharmacies June-July 2018. Within the first section
of the survey participants were informed before participation that completion of the question-
naire was voluntary, they may withdraw at any time, they did not have to answer any question
that they did not feel comfortable answering. It was confirmed that all submissions would be
anonymous and once surveys were submitted data could not be attributed to them as an
individual.
Data analysis
Descriptive statistics (frequencies, counts, standard error of count, percentages with related
standard error, Means with related standard error and 95% Confidence Intervals) were gener-
ated using SPSS software version 25 (IBM Corporation, Armonk, NY, USA). to reach quantita-
tive conclusions. Chi square statistical tests was used to determine the association between
variables where appropriate. Two-tailed t-test analysis within subjects was conducted to deter-
mine the significance of each quality attribute measured. The significance level was set at
P<0.05. Free text answers were collated and thematically analyzed to reach qualitative
conclusions.
Results
A total of 271 pharmacists participated in completing the survey: 144 pharmacists who worked
in RMS (8% more than the needed sample) and 127 CP (7% more than the needed sample). In
both cases the expected participant response rate was surpassed.
Participant’s demographic
The majority of participants were female: 70.1% (N = 101) for the RMS pharmacists and 72.4%
(N = 92) CP. Participant age distribution is shown (Table 1)
Specialty level and specialty fields at RMS
Pharmacists at RMS were categorized based on their specialty fields and ranking level. Unfor-
tunately, CP in Jordan do not have this system. As seen (Table 2) most RMS pharmacists were
ranked as specialists (41.7%), and there were a few participants who still under RMS training
(2.8%). Regarding specialty fields, 57.6% (N = 83) of RMS pharmacists have supply related
roles, and 40.3% (N = 58) have clinical roles. Three RMS pharmacists were reported as having
no specialty field as they perform a mix of duties.
Table 1. Age distribution for RMS and CP participants.
Royal Medical Services (RMS) Community Pharmacists (CP)
Age range Percent (%) N Age Range Percent (%) N
22–30 30.6 44 22–30 58.3 74
31–40 44.4 64 31–40 20.5 26
41–50 22.9 33 41–50 12.6 16
51–60 2.1 3 51–60 5.5 7
61–65 0 0 61–65 0.8 1
>65 0 0 >65 1.6 2
https://doi.org/10.1371/journal.pone.0255026.t001
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Ranking level to the specialty field was illustrated (Table 3). Almost similar distribution (X2
= 0.1577, df = 1, p = 0.69) of specialists in both fields; 25 (17.4%) and 33 (22.9%), for clinical
related and supply related fields, respectively. On the other hand, the lowest proportion of clin-
ical related employees was resident 1 (0.7%) compared to under-training pharmacists 2 (1.4%)
for the supply field.
Pharmaceutical education and training infrastructure
Results showed that training was documented in a written policy for most RMS staff (40.9%)
and not documented in writing for almost an equivalent number of CP (41.7%). Surprisingly,
more than 55% of pharmacists had neither policy nor infrastructure for CPD and training.
The proportion of CP who had a written policy was as low as 16.5% (Fig 1). Furthermore,
some participants believed that pharmaceutical education and training infrastructure should
be provided by authorities, 4.2% and 3.9% for RMS and CP, respectively. Written policies for
pharmaceutical education and training infrastructure was significantly higher in RMS com-
pared to CP (X2 = 34.811, df = 1, p<0.005).
Further analysis was carried out to compare the results within the RMS group based on
their specialty field (Table 4). There was a higher percentage of a written policy for pharmaceu-
tical education and training in supply related fields compared to the clinically related field
(64.4% and 32.2%, respectively). However, 63% of RMS clinical pharmacists received non-doc-
umented pharmaceutical education and training compared to 33.3% of those in the supply
field. In the same context, 39.6% (N = 57) pharmacists in RMS confirmed that the pharmaceu-
tical education and training policies were updated, 18.1% (N = 26) denied any updates, and
19.4% (N = 28) do not know if there were any updates of the policies. There were no
Table 2. Distribution of RMS pharmacists based on their specialty fields and specialty levels.
Specialty level Specialty fields
Category Percent (%) N Category Percent (%) N
Specialist assistance 7.6 11 Clinical related 40.3 58
Senior specialist 10.4 15
Specialist 41.7 60
Qualify resident 7.6 11 Supply related 57.6 83
Resident 26.4 38
Consultant 3.5 5
Under training 2.8 4
https://doi.org/10.1371/journal.pone.0255026.t002
Table 3. Distribution of the specialty level based on the specialty fields.
Specialty Field
Clinical Related Supply Related
Specialty Level Count Standard Error of Count Percent(%) SE (%) Count SE Percent (%) SE (%)
Specialist assistance 5 2 3.5 1.5 6 2 4.2 1.7
Senior specialist 6 2 4.2 1.7 9 3 6.3 2.0
Specialist 25 5 17.4 3.2 33 5 22.9 3.5
Qualify resident 14 4 9.7 2.5 23 4 16.0 3.1
Resident 1 1 0.7 0.7 4 2 2.8 1.4
Consultant 5 2 3.5 1.5 6 2 4.2 1.7
Under training 2 1 1.4 1.0 2 1 1.4 1.0
https://doi.org/10.1371/journal.pone.0255026.t003
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differences in the written policies among clinical and supply related fields within RMS phar-
macists (X2 = 1.213, df = 1, p = 0.271)
Strategies and programs for personal development and leadership skills
Unfortunately, only 19.4% of RMS pharmacists and 18.1% of CP confirmed the presence of a
written policy for personal development and leadership in their workplace (Fig 2). It could be
depicted that many RMS pharmacists 45.1% (N = 65) believed that personal development and
leadership skills resulted from experience. Almost one third 34.6% (N = 44) of CP confirmed
the availability of non-documented strategies and programs for personal development and
leadership. A minority of both RMS and community pharmacies thought that strategies and
programs for personal development and leadership were the responsibility of authorities (6.3%
and 4.7%, respectively). Written strategies and programs for personal development and
Fig 1. Availability of documented pharmaceutical education and training infrastructure in Royal Medical Services and Community
Pharmacies.
https://doi.org/10.1371/journal.pone.0255026.g001
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leadership skills were significantly higher in RMS compared to community pharmacies (X2 =
3.766, df = 1, p = 0.052).
Taking into consideration the specialty fields within the RMS group (Table 5) results show
that written policy for personal development and leadership were observed at higher extent
within the supply related field compared to the clinical related field (64.4% and 39.3%, respec-
tively). In the same context, higher proportion of staff at supply related field (60%, N = 39)
Table 4. The availability of pharmaceutical education and training based on the specialty field within RMS group.
Clinical Related Supply Related












Yes and there is a written policy for training
and education
19 4 32.20% 6.10% 38 5 64.40% 6.20%
Yes, but not written 17 4 63.00% 9.30% 9 3 33.30% 9.10%
It is the responsibility for authorities (for
example, Pharmacist Association and
others)
0 . 0.00% . 6 2 100.00% .
Education and training comes by
experience
20 4 44.40% 7.40% 25 5 55.60% 7.40%
No, no need for such infrastructure
everything is clear
2 1 40.00% 21.90% 3 2 60.00% 21.90%
https://doi.org/10.1371/journal.pone.0255026.t004
Fig 2. The availability of strategies and programs for personal development and leadership skills in Royal Medical
Services and Community Pharmacies.
https://doi.org/10.1371/journal.pone.0255026.g002
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considerd experience as main source for development and leadership skills compared to clini-
cal related field (40%, N = 26). About updating strategies and programs for personal develop-
ment and leadership in RMS, participants responded equally that the strategies were updated.
There was no significant difference in the written strategies for personal development among
clinical and supply related fields in the RMS (X2 = 0.029, df = 1, p = 0.865).
Incentives and rewards
Results show that 34.7% (N = 50) and 33.9% (N = 43) were receiving a clear and well-docu-
mented incentive schemes in RMS and CP, respectively. On the other hand, 21.5% (N = 31)
and 23.6% (N = 30) were receiving non-fixed scheme of incentives in RMS and CP, respec-
tively. 30.6% (N = 44) of the RMS pharmacists were only receiving their salaries despite of the
good working and superior achievements compared to 11.8% (N = 15) for CP. Amazingly, 0%
of pharmacists at community pharmacy confirmed that an incentive scheme was unnecessary
compared with 10.2% of the RMS staff (Fig 3).
Taking into consideration the specialty fields within the RMS group (Table 6), results show
that both clinical and supply related fields are receiving an explained and well documented
incentive for research at the same extent. Interestingly, higher proportion of the supply related
field pharmacists (57.7%, N = 41) are only receiving their salaries despite their research work
compared to (38.0%, N = 27) for the clinical related field pharmacists of the same category.
There was no difference in the updating of research incentives between clinical and supply
related fields in the RMS (X2 = 0.322, df = 1, p = 0.570).
Availability of software programs that aid working practices
The availability of software program that includes all the commercially available medicines
along with the available strengths, uses, side effects, drug-drug interactions, prices, and the
inventory helps in managing the work. Results show 58.3% (N = 84) and 64.6% (N = 82) have
a software program for work management in RMS and CP, respectively. Whereas 38.2%
(N = 55) and 29.1% (N = 37) responded that they do not have such programs in the RMS and
CP, respectively. The difference in the presence of software at the workplace between RMS and
CP was not significant (X2 = 1.725, df = 1, p = 0.189). Moreover, no significant difference was
found in the presence of software at the workplace between clinical and supply related fields in
the RMS (X2 = 0.424, df = 1, p = 0.515). Hakeem software was the most used software in RMS
(61.8%, N = 42) compared to Smart software in CP (54.2%, N = 45) (Fig 4).
Table 5. The availability of strategies and programs for personal development and leadership based on the specialty field within RMS group.
Clinical Related Supply Related














Yes and there is written policy for personal
development and leadership
11 3 39.3% 9.2% 38 5 64.40% 6.20%
Yes, but not written 10 3 38.5% 9.5% 16 4 61.5% 9.5%
It is the responsibility for authorities (for
example, Pharmacist Association and
others)
5 2 55.6% 16.6% 4 2 44.4% 16.6%
Personal development and leadership skills
come by experience
26 5 40.0% 6.1% 39 5 60.0% 6.1%
No, no need for such strategies and
programs, it is personal issues and efforts
6 2 46.2% 13.8% 5 2 38.5% 13.5%
https://doi.org/10.1371/journal.pone.0255026.t005
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Actions taken for unknown medical information
Participants were asked what action they take if they require further information to assist them
in their duties. The data shows that drug information and toxicology center were not effec-
tively used by CP nor RMS pharmacist. Both groups prefered published references such as
books or reputable websites (Fig 5).
Courses required for enhancing professional development
In a scale from 0 to 10, both groups surprisingly rated the need for having a particular course
in the same order as follows (Tables 7 and 8): First, advanced counseling and communication
Fig 3. The presence of reward or intensive scheme for good working and superior achievements in Royal Medical
Services and Community Pharmacies.
https://doi.org/10.1371/journal.pone.0255026.g003
Table 6. Relation between specialty fields and research incentives, and whether they are regularly updated in RMS.
Clinical Related Supply Related












Incentives Yes, it is clearly explained
and well-documented
21 4 36.2% 6.3% 21 4 25.3% 4.8%
Yes, but its not clear nor
fixed term
10 3 17.2% 5.0% 16 4 19.3% 4.3%
No, I only receive my
salary and that is it
27 5 46.6% 6.5% 41 5 49.4% 5.5%
Regular
updating
Yes 18 4 31.0% 6.1% 17 4 20.5% 4.4%
No 11 3 19.0% 5.1% 14 4 16.9% 4.1%
I do not know 12 3 20.7% 5.3% 23 4 27.7% 4.9%
https://doi.org/10.1371/journal.pone.0255026.t006
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skills (Mean rates for RMS and CP were 8.99±0.145, CI 95% = 3.70–4.28 and 9.37±0.096, CI
95% = 4.18–4.56). Second: Personal development skills (8.92±0.142, CI 95% = 3.64–4.20 and
9.02±0.145, CI 95% = 3.73–4.30). Third, Pharmaceutical health promotion (8.05±0.180, CI
95% = 2.70–3.41 and 8.57±0.159, CI 95% = 3.26–3.89).
Traditional modules related to work
Participants were asked about which traditional modules were related to their work (Table 9).
For both groups’, participants considered therapeutics as the most commonly used module
after graduation (34.3%) followed by Pharmacology (26.6%) The “Over the counter course”
was used mostly by CP (37.0%), but not RMS pharmacists (1.4%).
Discussion
As detailed, the profession of pharmacy is changing in terms of job role- increasing clinical
activity, this is accompanied by ever-increasing production and clinical introduction of novel
chemical entities and therapeutic technologies [24].
Fig 4. Type of software used in pharmaceutical services. (A) software used in Royal Medical Services (RMS). (B)
software used in Community Pharmacies.
https://doi.org/10.1371/journal.pone.0255026.g004
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In 2013, the World Health Organization (WHO) issued guidance emphasizing the need for
Continuous Education and training for healthcare providers, including pharmacists [45]. The
groundwork of pharmacy services is usually based on two factors; robust and well-reputed aca-
demic pharmacy institutions and appropriate pharmacist training. The former depends on the
academic institution of choice for undergraduate and graduate studies. The latter, however, is
a continual process that depends on the stakeholders’ efforts and concern of developing their
employees’ knowledge and skills. Requirements for healthcare professional training must have
input from all key stakeholders including future employers, existing healthcare professionals,
Fig 5. Actions taken for unknown medical information in Royal Medical Services and Community Pharmacies.
https://doi.org/10.1371/journal.pone.0255026.g005
Table 7. RMS Pharmacist views on courses.
Course Name N Mean rate of the perceived need SE of mean 95% Confidence Interval of
the Difference
Lower Upper
Project Management 131 7.93� 0.175 2.58 3.28
Cosmetics 133 6.45� 0.248 0.96 1.94
Finance & Economy 133 7.80� 0.172 2.46 3.14
Personal Development Skills 133 8.92� 0.142 3.64 4.20
Pharmaceutical Health Promotion 133 8.05� 0.180 2.70 3.41
Advanced counselling and Communication Skills 133 8.99� 0.145 3.70 4.28
Ethical Codes for Medical Practice 133 7.93� 0.175 3.24 3.84
� P<0.005, based on test value = 5.
https://doi.org/10.1371/journal.pone.0255026.t007
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patients and their representatives, local authorities, the professional regulator and government.
Collectively they must ensure the sustainable development of an education programs to gener-
ate healthcare professionals fit for purpose [46]. Hence, governmental bodies in Jordan which
regulate health pharmacutical services such as the Ministry of Health (MOH) and Jordan Phar-
maceutical Association (JPA) should set standards, processes, and policies for life-time phar-
macists’ education and training to meet current and future needs [47].
The present study outlines the current situation regarding pharmaceutical education and
training at both private and public sectors in Jordan, represented by community pharmacies
and RMS, respectively. This meets an undocumented area within the field of Jordanian phar-
macy practice and education literature. In terms of findings relating to CE and CPD, similar
results reporting the lack of structured continuing pharmaceutical education were obtained to
those of others [4, 48, 49]. The need for a documented and a well-based CE strategy was raised
by Anderson and colleagues [50]. This study emphasized the need for a tailored and docu-
mented educational strategy that meets the needs of both the workforces as well as the commu-
nities that they serve.
Implementation of leadership training in pharmacy practice is a philosophy that must be
considered by pharmacy educators and workforces worldwide. To achieve an implementation
of a sustainable leadership system, various elements are required such as administrative and
financial support, supportive institutional cultures, focused undergraduate leadership and
other ‘soft skills’ courses and activities, and postgraduate and employees’ education and train-
ing opportunities [51]. Leadership and self-development skills are typically expected behaviors
rather than rewarded skills, therefore individuals with inherited leadership mentality are more
willing to actively demonstrate these skills at work. It is observed from the present study that
45.1% and 30.7% of RMS and community pharmacists, respectively believe that leadership and
Table 8. Community pharmacists views on courses that should be required for pharmacists to complete.
Course Name N Mean rate of the perceived need SE of mean 95% Confidence Interval of
the Difference
Lower Upper
Project Management 127 8.06� 0.173 2.71 3.40
Cosmetics 127 8.11� 0.173 2.77 3.45
Finance & Economy 127 8.04� 0.187 2.67 3.41
Personal Development Skills 125 9.02� 0.145 3.73 4.30
Pharmaceutical Marketing (Promotion) 127 8.57� 0.159 3.26 3.89
Advanced counselling and Communication Skills 127 9.37� 0.0960 4.18 4.56
Ethical Codes for Medical Practice 127 8.2� 0.168 2.87 3.54
� P<0.005, based on test value = 5.
https://doi.org/10.1371/journal.pone.0255026.t008
Table 9. Traditional modules which mostly were used after graduation.
Course Community Pharmacists The Royal Medical Services Total
Over the counter 47 (37.0%) 2 (1.4%) 49 (18.1%)
Therapeutics 38 (29.9%) 55 (38.2%) 93 (34.3%)
Pharmacology 37 (29.1%) 35 (24.3%) 72 (26.6%)
Pharmaceutical industry 0 (0%) 5 (3.5%) 5 (1.8%)
Physical Pharmacy 1 (0.8%) 0 (0%) 1 (0.4%)
Other 4 (3.1%) 47 (32.6%) 51 (18.8%)
Total 127 (100%) 144 (100%) 271 (100%)
https://doi.org/10.1371/journal.pone.0255026.t009
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development skills come from experience. This echoes the findings of Smith and colleagues
[52] who found that pharmacy residences exposed to leadership experience either, validated
their prepossessed future interest in a leadership role, or increased their interest in leadership
via the obtained skills from non-directed experiences. Such experiences helped participants to
obtain leadership skills including decision-making, negotiation, and communication with co-
workers.
Our study showed that -in Jordan- there is a need for directed and formal leadership train-
ing, only 19.4% and 18.1% of the RMS and CP reported the presence of a written policy for
personal development and leadership in their workplace, and many believe that responsible
authorities such as the MOH and JPA should provide such training to pharmacists. Zilz and
colleagues [53] argued that learning personal development and leadership is a critical compo-
nent of enabling successful leadership. This entails reading relevant journals and textbooks
regularly, as well as involvement in local and international formal programs to boost the
required knowledge. The leadership programs should include learning, analyzing, questioning,
and mentoring leaders. As detailed in the introduction how best to implement and assess this
using validated measures is still an area of debate [1].
The concept of performance incentives for healthcare staff is not well established in develop-
ing countries. Within the context of pharmacy there is also the potential for pharmacy busi-
nesses to seek financial profits over providing performance-driven reimbursement or incentives
[54]. However, recent research and recommendations found that the implementation of phar-
macy incentives can enhance pharmacy services [55, 56]. Within our survey participants
reported relatively low work incentives in both community and RMS settings. Similar results
were obtained in other studies conducted in low and middle-income countries including Iran,
Malaysia, Thailand, Bangladesh, Nepal, Pakistan, Yemen Arab Republic, and Syria [54, 57, 58].
Other ways to improve or facilitate CE and CPD is pharmacist engagement with research.
Peterson and colleagues report that pharmacists are willing to participate in research to
enhance their profession, provide better services, update their knowledge toward disease man-
agement, and for personal interest [37]. Pharmacists’ involvement in research not only benefits
pharmacists but aids in solving practice-related issues and identification of areas for further
research to enhance patient care [36]. However, various challenges face pharmacists’ involve-
ment in research including lack of time, never being approached, low collaborations between
academia and pharmacies, and limited finances including grants to facilitate research imple-
mentation and buy pharmacists’ time for participation, particularly for community pharma-
cies [35, 37, 59].
Typically, hospital pharmacies are approached to participate more in research than com-
munity pharmacies. This study reflects similar trends where greater engagement with research
was noticed in RMS participants compared to CP. In the context of this study, participants
were not asked to explain why this might be the case but the authors propose that this differ-
ence may be attributed to the economic stress, limited staff numbers profit-making/ sales-ori-
ented base of community pharmacy businesses. However there are numerous examples of
successful community based interventions including community pharmacy health checks
[60], implementation of extended clinical services through patient group directives [61],
COPD screening [62] and pharmacogenomic testing [63] among others.
Reports indicate that financial incentives may be a driving factor for the involvement of
pharmacists in research [34, 64]. Nonetheless, pharmacist’s involvement in research will
develop their ability to provide evidence-based and improved patients services. Documented
and well-structured strategies to increase research engagement include promotions, establish-
ing links between practicing pharmacists and academia, and having access to grants to fund
projects are essential for both community and hospital pharmacies [34, 37].
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Globally a range of software systems are used to facilitate safe medication management includ-
ing efficient medicines procurement, decreasing prescription dispensing errors, identification of
and avoiding potential drug-related interactions standardization of processes and availability of
automated information [65]. The medication system management in both inpatient and outpa-
tient healthcare is a multifactorial interaction system that requires the use of health information
technology. Such employment was reported by participants in the present study, where both
groups highly reliant on software. Similar results were obtained by other studies [66–69].
Conclusion
This research shed the lights on professional development perspectives of pharmacists, who
working in Royal Medical Services and Community Pharmacies. Development aspects investi-
gated were as follows: continuous education, training infrastructure, leadership skills, rewards
and Incentives, using of digital services and management software, finally, exploring options
for better academic support delivered to pharmacists.
Taken together, the findings from this study support the crucial need to create a bespoke,
written and well documented postgraduate pharmacists’ educational strategies, that encoun-
ters not only academic perspectives, but also consider aspects as personal development, and
leadership skills. Despite the positive impact of incentive schemes and rewards for superior
achievements, such concepts are not effectively utilized to enhance pharmacist’s performance.
The present study highlighted many skills that would enhance professional development. The
highest rated skills were: Advanced counselling and Communication skills, Personal develop-
ment skills and pharmaceutical health promotion.
Recommendations and future work
Based on the received responses, the authors recommend setting guidelines in terms of occu-
pational education and training, personal development and leadership skills training, in addi-
tion to schemes of incentives and rewards by the relevant authorities in Jordan such as the
Ministry of Health and the Jordan Pharmaceutical Association.
The current work can be extended by expanding the sample size to include other phar-
macy-related occupations such as pharmacists working in public and private hospitals,
research and development departments in the pharmaceutical factories, pharmacists working
in the academic fields, and medical representatives and pharmaceutical marketing teams.
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